BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30214288)

  • 1. Incidence of bone metastasis and factors contributing to its development and prognosis in newly diagnosed renal cell carcinoma: a population-based study.
    Guo Q; Zhang C; Guo X; Tao F; Xu Y; Feng G; Han X; Ren Z; Zhang H; Zhang P; Wang X; Wang G
    Cancer Manag Res; 2018; 10():2935-2944. PubMed ID: 30214288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based evaluation of the risk factors and prognosis among renal cell carcinoma patients with initially diagnosed lung metastases.
    Zhang Z; Liang C; Hou B; Zhou L
    Actas Urol Esp (Engl Ed); 2021 Sep; 45(7):498-506. PubMed ID: 34332926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Brain Metastases in Patients with Renal Cell Carcinoma.
    Ke ZB; Chen SH; Chen YH; Wu YP; Lin F; Xue XY; Zheng QS; Xu N; Wei Y
    Biomed Res Int; 2020; 2020():6836234. PubMed ID: 32219138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort.
    Sun M; De Velasco G; Brastianos PK; Aizer AA; Martin A; Moreira R; Nguyen PL; Trinh QD; Choueiri TK
    Eur Urol Focus; 2019 May; 5(3):474-481. PubMed ID: 29311016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Metastases Pattern in Newly Diagnosed Metastatic Bladder Cancer: A Population-Based Study.
    Zhang C; Liu L; Tao F; Guo X; Feng G; Chen F; Xu Y; Li L; Han X; Baklaushev VP; Bryukhovetskiy AS; Wang X; Wang G
    J Cancer; 2018; 9(24):4706-4711. PubMed ID: 30588255
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical correlates and prognostic value of different metastatic sites in metastatic renal cell carcinoma.
    Abdel-Rahman O
    Future Oncol; 2017 Sep; 13(22):1967-1980. PubMed ID: 28836445
    [No Abstract]   [Full Text] [Related]  

  • 7. Advanced Hepatocellular Carcinoma with Bone Metastases: Prevalence, Associated Factors, and Survival Estimation.
    Guo X; Xu Y; Wang X; Lin F; Wu H; Duan J; Xiong Y; Han X; Baklaushev VP; Xiong S; Chekhonin VP; Peltzer K; Wang G; Zhang C
    Med Sci Monit; 2019 Feb; 25():1105-1112. PubMed ID: 30739123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone Metastasis in Renal Cell Carcinoma Patients: Risk and Prognostic Factors and Nomograms.
    Fan Z; Huang Z; Huang X
    J Oncol; 2021; 2021():5575295. PubMed ID: 34054954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics and prognosis of renal cell carcinoma patients with bone metastases].
    Zhai JP; Liu N; Wang H; Wang HD; Man LB
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(14):1068-1071. PubMed ID: 32294868
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of homogeneous and heterogeneous risk factors on the incidence and prognosis of brain metastases in patients with hepatocellular carcinoma.
    Lin X; Zhang P; Huang R; Huang Y; Sun J; Zheng H; Tian X; Wang X
    Ann Palliat Med; 2020 Sep; 9(5):2654-2667. PubMed ID: 32921091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of bone metastases in newly diagnosed colorectal cancer: a real-world analysis in the SEER database.
    Guo X; Zhang C; Ma W; Tian F; Xu G; Han X; Sun P; Baklaushev VP; Bryukhovetskiy AS; Wang G; Ma Y; Wang X
    Int J Colorectal Dis; 2019 Mar; 34(3):533-543. PubMed ID: 30617414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of resection and systemic therapy on the survival of patients with brain metastasis of metastatic renal cell carcinoma.
    Du Y; Pahernik S; Hadaschik B; Teber D; Duensing S; Jäger D; Hohenfellner M; Grüllich C
    J Neurooncol; 2016 Oct; 130(1):221-228. PubMed ID: 27538910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre.
    Ruatta F; Derosa L; Escudier B; Colomba E; Guida A; Baciarello G; Loriot Y; Fizazi K; Albiges L
    Eur J Cancer; 2019 Jan; 107():79-85. PubMed ID: 30551078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do renal cell carcinoma patients with brain metastases still need nephrectomy?
    Zhuang W; Li Y; Chen P; Wang J; Liu W; Chen J
    Int Urol Nephrol; 2019 Jun; 51(6):941-949. PubMed ID: 30953259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical intervention in renal cell carcinoma patients with lung and bronchus metastasis is associated with longer survival time: a population-based analysis.
    Lin S; Zheng Y; Qin Z; Hu X; Qi F; Yin R; Xu L; Li X
    Ann Transl Med; 2019 Jul; 7(14):323. PubMed ID: 31475193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma.
    Rosiello G; Palumbo C; Knipper S; Pecoraro A; Luzzago S; Tian Z; Larcher A; Capitanio U; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Urol Oncol; 2020 May; 38(5):537-544. PubMed ID: 32122729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
    Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
    BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic renal cell carcinoma: Patterns and predictors of metastases-A contemporary population-based series.
    Chandrasekar T; Klaassen Z; Goldberg H; Kulkarni GS; Hamilton RJ; Fleshner NE
    Urol Oncol; 2017 Nov; 35(11):661.e7-661.e14. PubMed ID: 28728748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence, associated factors for bone metastases development and prognosis in newly diagnosed ovarian cancer: a large population based real-world study.
    Zhang C; Guo X; Peltzer K; Ma W; Qi L; Zhang Y; Han X; Baklaushev VP; Yao Y; Wang G; Chekhonin VP; Wang X; Ma Y
    J Cancer; 2019; 10(14):3133-3139. PubMed ID: 31289583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.